What did @aubergine_avenger actually say?
The creator makes a sweeping claim: that Semax, a Russian peptide nasal spray, fixes ADHD by simultaneously correcting low dopamine, low serotonin, and low GABA, all within "20 to 30 minutes." The pitch goes further. Use it daily for a few weeks, they say, and you can "seize taking" it entirely, because the brain has been "reprogrammed" to enjoy tasks it previously hated. The changes, they claim, are permanent.
This is not a modest claim. This is a claim that a nasal spray can rewrite the neurological basis of a chronic condition and then make itself unnecessary. The creator frames this with genuine enthusiasm, calling Semax an "unbelievable compound" and a "real game changer." The disclaimer about not encouraging unapproved compounds is in the caption, not the video itself, which is doing a lot of persuasive heavy lifting in 90 seconds.
Does the science back this up?
Partially, in narrow and heavily caveated ways. The bulk of the evidence comes from Russian and Eastern European research, most of it on small samples or animal models, which matters enormously when evaluating these claims.
Semax is a synthetic heptapeptide derived from ACTH(4-7). It has been used in Russia since the 1990s as a registered nootropic and is approved there for conditions including stroke recovery and cognitive impairment. It is not approved by the FDA for any indication.
Research does show Semax influences brain-derived neurotrophic factor (BDNF) expression. A study by Dolotov et al. (2006, Journal of Neurochemistry) found intranasal Semax increased BDNF in rat hippocampal and basal forebrain regions. BDNF plays a role in neuroplasticity, which is the legitimate kernel inside the "reprogramming" framing. There is also evidence suggesting Semax modulates dopaminergic activity, though describing it as simply "fixing low dopamine" badly oversimplifies a complex receptor-level interaction. The serotonin and GABA claims are much weaker, supported mainly by indirect inference rather than direct clinical trial data in humans.
What did they get wrong (or right)?
The ADHD neuroscience in this video is reductive to the point of being misleading. The creator says ADHD means dopamine is low, serotonin is low, and GABA is low. That framing is outdated and incorrect.
- ADHD is not a simple deficiency of three neurotransmitters. The current consensus, outlined in reviews such as Faraone et al. (2021, Neuroscience and Biobehavioral Reviews), points to dysregulation of dopamine and norepinephrine signaling in prefrontal circuits, not global deficits in dopamine, serotonin, and GABA simultaneously.
- The claim that Semax can "fix" all three in 20 to 30 minutes has no peer-reviewed clinical trial support in ADHD populations. There are no published randomized controlled trials of Semax specifically for ADHD.
- The "permanent reprogramming" claim is the most irresponsible part of the video. No evidence supports the idea that short-term Semax use produces durable neurological changes that persist after stopping. BDNF upregulation in rodent studies is not evidence of permanent behavioral rewiring in humans.
What they got partially right: Semax does have a real pharmacological profile. The BDNF-related neuroplasticity angle is at least grounded in published biology, even if the conclusions drawn here go far beyond what the data supports.
What should you actually know?
Semax is not available as an FDA-approved medication in the United States. Sourcing it means buying from gray-market vendors with no regulatory quality oversight. Purity, concentration, and sterility are not guaranteed, and that matters enormously for something you are putting in your nose and absorbing nasally into your brain.
If you have ADHD and are looking at peptide-adjacent or nootropic interventions because conventional treatments have not worked, that is a legitimate frustration worth discussing with a clinician. What is not legitimate is concluding from a 90-second TikTok that a Russian peptide will permanently rewire your operating system after a few weeks of use.
Telehealth providers operating under US regulations cannot prescribe Semax. Any platform claiming otherwise should be a red flag. If you are considering any peptide therapy, the conversation starts with a licensed provider reviewing your full medical history, not a social media video.
The creator's disclaimer exists. It is not enough to offset a video that confidently attributes specific neurochemical mechanisms and permanent outcomes to an unproven compound, without a single study cited.